Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
ImmunoGen, Inc.
| Metric | ImmunoGen, Inc. Healthcare |
|---|---|
| Quality Score | 48 / 100 |
| Revenue (latest) | $109M |
| Net income (latest) | −$223M |
| Operating margin | −203.1% |
| Net margin | −204.9% |
| Return on equity | −143.1% |
| Return on assets | −63.9% |
| Return on capital (ROCE) | −97.3% |
| Debt / equity | 1.24× |
| Revenue growth (YoY) | 55.7% |
| Altman Z″ (distress) | -15.81 |
| Accruals / assets | 2.0% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.